Benzylideneacetone (CAS No 122-57-6) is a compound with significant applications in biomedical research particularly in the study of anti-cancer and anti-inflammatory properties Originating from organic synthesis its mechanism of action often involves the inhibition of NF-kB and other signaling pathways targeting cellular processes like apoptosis and proliferation It exhibits in vitro activity typically within the nanomolar to low micromolar range demonstrating potency in various assays Applications include use in cell models such as human carcinoma cell lines and animal studies to explore therapeutic potentials It is also utilized in drug screening processes for its ability to modulate key biological pathways Experimental concentrations typically depend on the specific research design This compound s versatility makes it a valuable tool in the exploration of novel therapeutic strategies and the understanding of complex biochemical mechanisms